Imagine the future with us
"Imagine the future with us" is a lecture series to mark the 125th anniversary of the OHSU School of Medicine. Throughout this series, we invite you to think creatively about our future and the future of our integrated missions of discovery, health care, education and outreach.
What might the school look like 125 years from now (or perhaps more realistically, 25 years from now)? How will we have changed and what value will we bring to our communities? What new paradigm shifts across all our missions will technology, innovation and collaboration catalyze? What breakthroughs are on our horizon that could reshape academic medicine?
The School of Medicine has invited speakers who will catalyze compelling conversations about the opportunities of the future and the role of academic medicine in the 21st century and beyond.
Visit the bottom of this page for information about past lectures (video is available where indicated).
Eric Topol, M.D., director, Scripps Translational Science Institute, author
How digitizing human beings reboots the future of medicine
June 12, 2013 - 12 p.m.
OHSU Auditorium / Add to your calendar
Pioneering geneticist and cardiologist Eric Topol, M.D., will share his perspective on the coming era of "big data" and the transformative impact of the digitization of medicine, focusing on the convergence of genomics and innovative wireless health care "apps" — a topic covered in Dr. Topol's recent book The Creative Destruction of Medicine (Basic Books). Will we soon be checking vital signs on our phones? Dr. Topol is currently the director of the Scripps Translational Science Institute in La Jolla, Calif., where he also holds an endowed chair of innovative medicine. Previously, he was chief of cardiovascular medicine at the Cleveland Clinic, a 2009 TEDMED speaker, and named the #1 most influential Physician Executive in 2012 by Modern Healthcare.
School of Medicine partner: Oregon Clinical & Translational Research Institute
Sir Bruce Ponder, M.D., Ph.D., FRS, professor of Oncology and director, Cancer Research UK Cambridge Research Institute, University of Cambridge
July 9, 2013 - 4 p.m.
OHSU Hospital, 8th Floor Auditorium
Sir Bruce Ponder will update us on his research to identify genes that underlie susceptibility to cancer and the practical applications of that knowledge. He will also discuss the essential role of collaboration between research and clinical entities to more rapidly translate discoveries into patient care, and realizing a future of personalized medicine. Dr. Ponder is director and professor of oncology at the Cancer Research UK Cambridge Research Institute. He is world-renowned for his pioneering research into discovering genes that affect our risk of common cancers, particularly breast cancer. He is also investigating the genetics of lung cancer. Dr. Ponder's team helped to identify the breast cancer susceptibility genes BRCA1 and BRCA2, and conducted the first genome wide association study in breast cancer.
School of Medicine partner: OHSU Knight Cancer Institute_________________________________________________________________________________________________
Juan Enriquez, MBA, TED speaker and futurist
Joined in a special kick-off discussion by Brian Druker, M.D., Joe Gray, Ph.D., Robert Hitzemann, Ph.D. and Mary Stenzel-Poore, Ph.D.
The "life code" revolution: reshaping the global economy
November 14, 2012
OHSU Auditorium | Regrettably,video is unavailable of Mr. Enriquez's lecture.
Imagine a future in which the knowledge now emerging from life sciences has fundamentally transformed the economic and political landscape of the world. Now imagine the role of academic medicine in this Golden Age of the biosciences. Enriquez was joined by four of OHSU's most innovative faculty leaders and thinkers — Brian Druker, M.D., Joe Gray, Ph.D., Robert Hitzemann, Ph.D. and Mary Stenzel-Poore, Ph.D.— to ponder the culture, organization and role of academic medicine and research in this new paradigm. Enriquez is a leading authority on the economic impact of life sciences on business and society and an internationally known business leader and entrepreneur. He is managing director of Excel Venture Management. Prior to this, Enriquez was the founding director of the Harvard Business School's Life Sciences Project. Many of his innovative thoughts are captured in his bestselling book, As The Future Catches You, which provided a blueprint of how a bio-based economy changes industries and corporations. His most recent publication is an eBook, Homo Evolutis: A Short Tour of our New Species, which describes a world where humans increasingly shape their environment, themselves and other species. Enriquez will also spoke at the Portland Art Museum on November 14.
George Mejicano, M.D., senior associate dean for education, OHSU School of Medicine
Adaptation and evolution in education: Surviving the impact of the comet that's headed our way
January 15, 2013
OHSU Auditorium | Watch the Video
The world of education is changing rapidly — some people predict universities won’t even exist in 10 years. George Mejicano, M.D., speculated on several future scenarios in the world of education in his lecture. In his role as senior associate dean for education, Dr. Mejicano is part of a mission-integrated senior leadership team, which reflects the school's commitment to collaboration and partnerships across all missions. Dr. Mejicano has received numerous awards for leadership and teaching and has served in many national leadership positions, including service on the Board of Directors of the Accreditation Council for Continuing Medical Education and the Board of Scientific Counselors of the National Center for Infectious Diseases of the U.S. Centers for Disease Control and Prevention. He is also a consultant to the American Board of Medical Specialties on issues related to continuing medical education and maintenance of certification. Dr. Mejicano joined OHSU in August 2012 from the University of Wisconsin School of Medicine and Public Health.
Amanda Bennett, author, executive editor of projects and investigations, Bloomberg News
Confronting the "cost of hope" in the U.S. health care system
February 4, 2013
OHSU Auditorium | Regrettably,video is unavailable of Ms. Bennett's lecture.
After the illness and death of her husband Terence, Pulitzer Prize-winning journalist Amanda Bennett applied her skills as an investigative reporter to uncover the "science, emotions, and costs" of his health care. Immersing herself, she wove together the fragments contained in seven years of health care records and mountains of medical bills with candid interviews of providers from dozens of institutions, all part of Terence's care.
In his review, Bill Gates called Bennett's resulting book The Cost of Hope (Random House) "...a perfect example of why all of the hard decisions about health care spending are just that." Bennett shared details and insights from her book, including fundamental questions it raises about future directions in health care reform. Bennett directs special projects and investigations for Bloomberg News, and was previously co-chair of the Pulitzer Prize Board, editor of The Philadelphia Inquirer, managing editor for The Oregonian, and bureau chief at The Wall Street Journal.
School of Medicine partner: OHSU Strategic Communications
Alan E. Guttmacher, M.D., director, Eunice Kennedy Shriver National Institute of Child Health and Human Development
The future of pediatrics research and practice
February 19, 2013
Vey Auditorium | Watch the Video
Alan E. Guttmacher, M.D., discussed some of the unique characteristics that distinguish today's pediatric population from previous generations, and highlighted emerging scientific opportunities that could lead to future advances in health care. A pediatrician and medical geneticist, Dr. Guttmacher is Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development — the focal point at the National Institutes of Health for research in pediatric health and development, maternal health, reproductive health, intellectual and developmental disabilities, and rehabilitation medicine, among other areas. Previously, he worked in various roles, including Deputy Director and Acting Director, at the National Human Genome Research Institute, where he oversaw the institute's efforts to advance genome research, integrate that research into health care, and explore the ethical, legal, and social implications of human genomics. Dr. Guttmacher is a graduate of Harvard Medical School and a member of the Institute of Medicine.
School of Medicine partners: Department of Molecular & Medical Genetics and Department of Pediatrics
Eric Dishman, Intel fellow and general manager, Intel Health Strategy & Solutions
Accelerating personal health: An entrepreneurial patient’s view of disruptive technologies and the promise of “OHSU Everywhere”
April 1, 2013
OHSU Auditorium | Watch the Video
Eric Dishman shared his perspective on how technology will reshape health care delivery, and even the definition of health care. Dishman is widely recognized as a global leader in health care innovation, user-centered design, and home and community-based technologies. Dishman founded Intel's first health care lab in 1999 and co-founded the Intel Digital Health Group. Trained as a social scientist, he leads an interdisciplinary team who builds upon Intel's 12-year study of the needs of over 1,000 patients and hundreds of clinicians in 20 countries to inform Intel's innovation and policy efforts.
School of Medicine partner: Department of Medical Informatics & Clinical Epidemiology, celebrating 10 years
John Benson, M.D., dean emeritus, OHSU School of Medicine
OHSU Medical Milestones: 125 Years of Healing, Teaching, and Discovery
April 12, 2013
OHSU Auditorium | Watch the video
Dr. Benson was a speaker in the History of Medicine Society lecture series, and provided a timely look back at the School of Medicine’s rich history. An educator and clinician, Dr. Benson became a faculty member at the School of Medicine in 1959. During his 18 years at OHSU, Dr. Benson was instrumental to the development of the Division of Gastroenterology, served on the OHSU Center for Ethics in Health Care, and was interim dean of the School of Medicine from 1992 to 1994. The annual Benson/Kendall Visiting Professorship lecture is named in his honor, along with John Kendall, Jr., M.D., for outstanding years served at the OHSU School of Medicine.
School of Medicine partner: OHSU Library
Steven Chu, Ph.D., Nobel Prize Winner, physicist and outgoing United States Secretary of Energy
Dr. Chu goes to Washington
April 23, 2013
OHSU Auditorium | Watch the Video
Human health and well-being depend on a healthy global environment. Steven Chu, Ph.D., discussed his vision of our energy future and how innovations in technology and public policy can help us/U.S. lead the world to a sustainable future. Dr. Chu is a distinguished scientist and co-winner of the Nobel Prize for Physics (1997). He served as the United States Secretary of Energy from January 2009 to April 2013. Prior to this appointment, Dr. Chu was director of the Lawrence Berkeley National Lab where he led the lab in pursuit of alternative and renewable energy technologies; he also taught at the University of California as a professor of physics and molecular and cell biology. Dr. Chu's research in atomic physics, quantum electronics, polymer and biophysics includes tests of fundamental theories in physics, the development of methods to laser cool and trap atoms, atom interferometry, and the study of polymers and biological systems at the single molecule level, and the development and application of nanometer resolution optical microscopy in biological and biomedical sciences. While a professor at Stanford, he helped start Bio-X, a multi-disciplinary initiative that brings together the physical and biological sciences with engineering and medicine. After his service as Secretary, he will return to Stanford as a member of the Physics and Molecular and Cellular Physiology Departments.
OHSU is pleased to concurrently welcome Dr. Chu as the 2013 Mark O. Hatfield lecturer.
School of Medicine partner: Department of Biomedical Engineering, OHSU Office of Community Relations
Mace L. Rothenberg, M.D., senior vice president of clinical development and medical affairs, Pfizer
Industry-academia collaboration: Developing novel therapeutics in oncology based on new genetic insights
May 21, 2013
Mace L. Rothenberg, M.D., led a conversation about the growing importance of industry-academia collaboration for discovery and drug development, using examples stemming from novel therapeutics in oncology and based on new genetic insights. Dr. Rothenberg is responsible for overseeing clinical research and development activities as well as post-marketing evaluation and monitoring for all Pfizer oncology products. Dr. Rothenberg came to Pfizer in 2008 after more than 20 years in academia where he focused on early-stage drug development, clinical trial design, and the coordinated laboratory-clinical evaluation of new therapies for gastrointestinal cancers. He is the recipient of the American Cancer Society's Lane W. Adams Quality of Life Award, honoring him as one of the nation's top cancer caregivers and the American Society of Clinical Oncology's Statesman Award, honoring him for more than 20 years of service to the organization, the specialty of oncology and cancer patients.
School of Medicine partner: Research Roadmap Task Force #6. Dr. Rothenberg’s lecture was also part of OHSU Research Week.